Davidd Chang News Today

ALLO | Complete Allogene Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

Compass Therapeutics (NASDAQ:CMPX – Get Rating) and Allogene Therapeutics (NASDAQ:ALLO – Get Rating) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, earnings, risk, dividends, analyst recommendations, institutional ownership and valuation. Institutional and Insider Ownership 54.3% of Compass Therapeutics shares […]

Shares of Allogene Therapeutics, Inc. (NASDAQ:ALLO – Get Rating) have received an average rating of “Buy” from the fifteen analysts that are currently covering the company, Marketbeat Ratings reports. Two investment analysts have rated the stock with a hold recommendation and eleven have assigned a buy recommendation to the company. The average 1-year price objective […]

Shares of Allogene Therapeutics, Inc. (NASDAQ:ALLO – Get Rating) have been assigned an average recommendation of “Buy” from the fifteen ratings firms that are covering the company, Marketbeat.com reports. Two equities research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company. The average twelve-month price […]

Vir Biotechnology (NASDAQ:VIR – Get Rating) and Allogene Therapeutics (NASDAQ:ALLO – Get Rating) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, risk, earnings, dividends, analyst recommendations, institutional ownership and profitability. Analyst Ratings This is a summary of current ratings and […]